Comparison of creatinine clearance estimation methods in patients with trauma

被引:39
作者
Davis, GA
Chandler, MHH
机构
[1] UNIV KENTUCKY, MED CTR, CLIN PHARMACOKINET SERV, LEXINGTON, KY 40536 USA
[2] UNIV KENTUCKY, COLL PHARM, LEXINGTON, KY USA
关键词
aminoglycosides; calculations; creatinine; dosage; equations; excretion; gentamicin; methodology; urine levels; weight;
D O I
10.1093/ajhp/53.9.1028
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The abilities of a modified Cockcroft-Gault equation and the standard equation to estimate creatinine clearance (CL(alpha)) in trauma patients were compared. The medical records of patients with stable renal function who had been treated for trauma and had had a 24-hour urine collection for creatinine measurement were reviewed. Creatinine concentrations in urine and serum were used to calculate the actual CL(alpha), which was normalized to 1.73 sq m. CL(alpha) was estimated by the modified equation (which normalized body weight to 72 kg) and by the standard equation using ABW, IBW, and dosing body weight (DBW). Values derived with the standard equation were normalized to 1.73 sq m. The predictive performances of the modified and standard equations in estimating the actual CL(alpha) were then compared. Fifty patients were enrolled. The standard equation using IBW or DBW produced estimates that differed significantly from the actual CL,. The modified equation and the standard equation using ABW did not differ significantly in bias or precision, but both were significantly less biased than the standard equation using IBW or DBW. The only significant difference among equations in precision was between the modified equation (the more precise) and the standard equation using IBW. There were no clinically significant differences among methods in gentamicin dosing simulations. The modified Cockcroft-Gault equation can be used to estimate Cl-alpha in trauma patients with stable renal function.
引用
收藏
页码:1028 / 1032
页数:5
相关论文
共 43 条
[1]  
[Anonymous], HOSP PHARM
[2]  
BAUMANN TJ, 1987, CLIN PHARMACY, V6, P393
[3]   TOBRAMYCIN IN RENAL IMPAIRMENT [J].
BECHTOL, LD ;
BLACK, HR .
AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 1975, 269 (03) :317-321
[4]  
BENNETT WM, 1993, DRUG PRESCRIBING REN
[5]  
Blouin RA, 1992, APPL PHARMACOKINETIC
[6]  
BOLTON S, 1990, PHARM STATISTICS PRA
[7]  
BONSNES RW, 1945, J BIOL CHEM, V158, P581
[8]  
BOYCE EG, 1989, CLIN PHARMACY, V8, P721
[9]   VARIABILITY OF CREATININE EXCRETION IN NORMAL SUBJECTS, MENTAL PATIENTS AND PREGNANT WOMEN [J].
CHATTAWAY, FW ;
HULLIN, RP ;
ODDS, FC .
CLINICA CHIMICA ACTA, 1969, 26 (03) :567-+
[10]   CREATININE CLEARANCE PREDICTIONS IN ACUTELY ILL PATIENTS [J].
CHRYMKO, MM ;
SCHENTAG, JJ .
AMERICAN JOURNAL OF HOSPITAL PHARMACY, 1981, 38 (06) :837-840